insights_auto
Why is IPSEY down 5,13%?
Dive Deeperchevron_right
IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
39,75 US$
arrow_downward
-5,13%(-2,15) 1D
5 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IPSEY...
Open
39,40 US$
High
39,75 US$
Low
39,40 US$
Mkt. cap
11,63 მლრდ.
Avg. vol.
472,00
Volume
9,64 ათ.
52-wk high
51,10 US$
52-wk low
32,68 US$
Beta
0,41
Shares outstanding
335,26 მლნ.
No. of employees
6 ათ.
Open
39,40 US$
High
39,75 US$
Low
39,40 US$
Mkt. cap
11,63 მლრდ.
Avg. vol.
472,00
Volume
9,64 ათ.
52-wk high
51,10 US$
52-wk low
32,68 US$
Beta
0,41
Shares outstanding
335,26 მლნ.
No. of employees
6 ათ.
News stories
From web sources and news partners
Ideal Investisseur
·
16 საათის წინ
Ipsen: Stock Dips Below €140.50 Support Then Recovers Above Key Level
Profile
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
About Ipsen ADR Rep 1/4 Ord Shs